Evidence map›Paper›PMID 32293262›Full record

ArticleBMC molecular and cell biology2020

PGRMC1 effects on metabolism, genomic mutation and CpG methylation imply crucial roles in animal biology and disease.

Bashar M Thejer, Partho P Adhikary, Sarah L Teakel, Johnny Fang, Paul A Weston, Saliya Gurusinghe, Ayad G Anwer, Martin Gosnell, Jalal A Jazayeri, Marina Ludescher and 13 more

Open access · goldAbstract read
In one paragraph

Article in BMC molecular and cell biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells.Journal of experimental & clinical cancer research : CR · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 10 institutions in 5 countries.

Bashar M ThejerSchool of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia.
Partho P AdhikarySchool of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia.
Sarah L TeakelSchool of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia.
Johnny FangSchool of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia.
Paul A WestonGraham Centre for Agricultural Innovation, Charles Sturt University, Boorooma Street, Wagga Wagga, NSW, 2678, Australia.
Saliya GurusingheGraham Centre for Agricultural Innovation, Charles Sturt University, Boorooma Street, Wagga Wagga, NSW, 2678, Australia.
Ayad G AnwerARC Centre of Excellence for Nanoscale BioPhotonics, Macquarie University, Sydney, NSW, 2109, Australia.
Martin GosnellARC Centre of Excellence for Nanoscale BioPhotonics, Macquarie University, Sydney, NSW, 2109, Australia.
Jalal A JazayeriSchool of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia.
Marina LudescherDepartment of Gynecology and Obstetrics, University Women's Hospital of Dusseldorf, Dusseldorf, Germany.
Lesley-Ann GrayAustralian Genome Research Facility Ltd., Victorian Comprehensive Cancer Centre, Melbourne, VIC, 3000, Australia.
Michael PawlakNMI TT Pharmaservices, Protein Profiling, 72770 Reutlingen, Germany.
Robyn H WallaceSchool of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia.
Sameer D PantSchool of Animal and Veterinary Sciences, Charles Sturt University, Boorooma Street, Wagga Wagga, NSW, 2678, Australia.
Marie WongKinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst, NSW, 2010, Australia.
Tamas FischerACRF Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, ACT, 2601, Australia.
Elizabeth J NewUniversity of Sydney, School of Chemistry, Sydney, NSW, 2006, Australia.
Tanja N FehmDepartment of Gynecology and Obstetrics, University Women's Hospital of Dusseldorf, Dusseldorf, Germany.
Hans NeubauerDepartment of Gynecology and Obstetrics, University Women's Hospital of Dusseldorf, Dusseldorf, Germany.
Ewa M GoldysARC Centre of Excellence for Nanoscale BioPhotonics, Macquarie University, Sydney, NSW, 2109, Australia.
Jane C QuinnGraham Centre for Agricultural Innovation, Charles Sturt University, Boorooma Street, Wagga Wagga, NSW, 2678, Australia.
Leslie A WestonGraham Centre for Agricultural Innovation, Charles Sturt University, Boorooma Street, Wagga Wagga, NSW, 2678, Australia.
Michael A CahillSchool of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, 2650, Australia. mcahill@csu.edu.au.
Charles Sturt University · AUDüsseldorf University Hospital · DEAustralian National University · AUMacquarie University · AUAGRF Ltd · AUGarvan Institute of Medical Research · AUNatural and Medical Sciences Institute · DEQuantitative BioSciences · USThe University of Sydney · AUUniversity of British Columbia · CA

Funding

Australian Research Council (AU) CE140100003Australian Research Council (AU) DE120102687Charles Sturt University (AU) N/AIraqi Cultural Attaché in Canberra (AUS) N/ARamaciotti Foundations ES2012/0051
6 · The paper itself

Abstract

backgroundProgesterone receptor membrane component 1 (PGRMC1) is often elevated in cancers, and exists in alternative states of phosphorylation. A motif centered on PGRMC1 Y180 was evolutionarily acquired concurrently with the embryological gastrulation organizer that orchestrates vertebrate tissue differentiation.

resultsHere, we show that mutagenic manipulation of PGRMC1 phosphorylation alters cell metabolism, genomic stability, and CpG methylation. Each of several mutants elicited distinct patterns of genomic CpG methylation. Mutation of S57A/Y180/S181A led to increased net hypermethylation, reminiscent of embryonic stem cells. Pathways enrichment analysis suggested modulation of processes related to animal cell differentiation status and tissue identity, as well as cell cycle control and ATM/ATR DNA damage repair regulation. We detected different genomic mutation rates in culture.

conclusionsA companion manuscript shows that these cell states dramatically affect protein abundances, cell and mitochondrial morphology, and glycolytic metabolism. We propose that PGRMC1 phosphorylation status modulates cellular plasticity mechanisms relevant to early embryological tissue differentiation.

Indexed as

PhosphorylationReceptors, ProgesteroneAnimalsCell DifferentiationCell LineDiseaseDNA MethylationEmbryologyEpigenomicsHumansMembrane ProteinsMiceMutationMutation RateProtein Processing, Post-TranslationalMembrane ProteinsPGRMC1 protein, humanReceptors, ProgesteroneCell deathCytochrome P450EmbryologyEpigeneticsGenomic sequenceHyperspectral autofluorescenceMetabolismOrganizerSteroid biology

Identifiers

PMID32293262
PMCPMC7160964
OpenAlexW3016022324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.